Side-by-side comparison of AI visibility scores, market position, and capabilities
Optometry and optical practice management software owned by VSP Global, serving independent eyecare practices across the United States.
Eyefinity is a Rancho Cordova, California-based optometry and optical practice management software company owned by VSP Global, the largest vision care benefits plan in the United States. Eyefinity provides practice management, electronic health records, and optical lab connectivity tools specifically designed for independent optometrists and optician-led optical retail businesses. The company's products include OfficeMate for practice scheduling, billing, and medical records; ExamWRITER for clinical charting and electronic prescriptions; and iMedicWare for optical point-of-sale and lab order management. Eyefinity's products are used by tens of thousands of eye care professionals across the U.S., many of whom are part of the VSP network of independent optometrists.\n\nEyefinity's connection to VSP Global gives it several advantages in the independent optometry market. VSP's vision care network includes a large proportion of independent optometrists who are naturally inclined toward Eyefinity software because of the seamless VSP insurance eligibility verification and claim submission integration that simplifies the billing workflow for VSP patients—which constitute a significant portion of most private-practice optometry patient volumes. This network integration effectively makes Eyefinity the path of least resistance for VSP-affiliated optometrists seeking practice management software, creating a built-in distribution advantage.\n\nEyefinity has been modernizing its product portfolio through cloud-based offerings and improved user interfaces as competitive pressure from newer optometry software entrants increases. The company competes with Compulink Healthcare Solutions, Revolution EHR, and Crystal Practice Management in the optometry practice management market. Eyefinity differentiates on its VSP integration depth, its large installed base in the VSP network, and the operational trust that comes from being backed by the dominant vision care benefits plan in the United States.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.